Found 4 matching trials
SEDPARK2: Post Marketing Surveillance to Observe Safety and Efficacy of Piribedil in Parkinson's Disease (PIR-002/K) N/A The objective of the Post Marketing Surveillance Study is to investigate th...
Show More Location
Medical Practice for Neurology
Learn More & Join Trial
PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term Therapy N/A Non-Ergot Dopamine agonists are meanwhile the drugs of first-choice in the ...
Show More Learn More & Join Trial
SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease N/A The aim of the non-interventional Post Marketing Study is to investigate th...
Show More Location
Multiple Locations
Learn More & Join Trial
Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists PHASE3 The purpose of this clinical trial is to investigate the effects of the non...
Show More Location
Multiple Locations
Learn More & Join Trial